Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03726268 · ClinicalTrials.gov registry record · Phase 4
Optimizing Outpatient Anesthesia (OSPREy-Outpatient Surgery Pain Relief Enhancement)
A Phase 4 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 4
- Development phase
- 907
- Enrollment target
NCT03726268: Completed Phase 4 study, sponsored by Duke University.
NCT03726268 is a Phase 4 study that has completed, run by Duke University. The registered enrollment target is 907 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (75% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03726268, a Phase 4 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 907 participants
- Enrollment target
Study Summary
The overall goal of this research is to improve perioperative pain treatment, decrease post-operative opioid consumption, diminish opioid related side effects, and reduce postop opioid prescribing (and hence opportunity for diversion, abuse, addiction, and fatal overdose).
Primary Outcome
Based on home diary and hospital record. Number of opioid tablets from PACU discharge to postoperative day (POD) 30 for Same Day subjects, and number of opioid tablets from POD 1 to POD 30 for Short-Stay subjects.
Interventions
- DRUG Methadone
- DRUG Hydromorphone
- DRUG Morphine
- DRUG Fentanyl
- DRUG Sufentanil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 907 participants |
| Start Date | 2018-11-29 |
| Est. Completion | 2024-01-30 |
| Phase | Phase 4 |
What the finished NCT03726268 record still lists
NCT03726268 is an interventional study that assigns participants to a tested intervention. The registered 907 participants enrollment target is mid-sized for trials with a published cap, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (75% higher).
The record links to 0 conditions, and to 5 interventions - of which Methadone is the first listed.
NCT03726268 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03726268 about?
NCT03726268 is a clinical study titled "Optimizing Outpatient Anesthesia (OSPREy-Outpatient Surgery Pain Relief Enhancement)". The overall goal of this research is to improve perioperative pain treatment, decrease post-operative opioid consumption, diminish opioid related side effects, and reduce postop opioid prescribing (and hence opportunity for diversion, abuse, addiction, and fatal overdose).
What is the current status of trial NCT03726268?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 907 participants. The study started on 2018-11-29. Estimated completion is 2024-01-30.
What interventions are being tested in trial NCT03726268?
The interventions under investigation include: Methadone (DRUG), Hydromorphone (DRUG), Morphine (DRUG), Fentanyl (DRUG), Sufentanil (DRUG).
Who is sponsoring clinical trial NCT03726268?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03726268's enrollment target sits among peer trials
907 81st of 2000 higher than 1,920 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05658497 · 908 participants
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
- NCT06216548 · 909 participants · NA
E-PRIME For Children With Medical Complexity
- NCT05769777 · 901 participants · Phase 2
Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
- NCT06131840 · 914 participants · Phase 1
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI